Toward clinical application of the Keap1-Nrf2 pathway.

[1]  J. G. Kenna,et al.  The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. , 2013, Antioxidants & redox signaling.

[2]  N. Khaper,et al.  Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. , 2013, Antioxidants & redox signaling.

[3]  T. Kohno,et al.  Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels , 2013, Molecular and Cellular Biology.

[4]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[5]  Takafumi Suzuki,et al.  Roles of Keap1–Nrf2 System in Upper Aerodigestive Tract Carcinogenesis , 2012, Cancer Prevention Research.

[6]  Satoru Takahashi,et al.  Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. , 2012, Free radical biology & medicine.

[7]  Alexander Böcker,et al.  Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. , 2012, Cell stem cell.

[8]  M. Sporn,et al.  Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease , 2012, Pharmacological Reviews.

[9]  K. Nakayama,et al.  Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks , 2012, Nucleic acids research.

[10]  Takafumi Suzuki,et al.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. , 2012, Free radical biology & medicine.

[11]  Masaaki Komatsu,et al.  Keap1 degradation by autophagy for the maintenance of redox homeostasis , 2012, Proceedings of the National Academy of Sciences.

[12]  M. Sporn,et al.  NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.

[13]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[14]  K. Furge,et al.  Chinese a Nti鄄 Cancer a Ssociation , 2022 .

[15]  Michelle R. Campbell,et al.  Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha , 2012, Nucleic acids research.

[16]  T. Iwawaki,et al.  A transgenic mouse model for monitoring oxidative stress , 2012, Scientific Reports.

[17]  I. Copple.  The Keap1-Nrf2 cell defense pathway--a promising therapeutic target? , 2012, Advances in pharmacology.

[18]  J. D. Engel,et al.  Embryonic Lethality and Fetal Liver Apoptosis in Mice Lacking All Three Small Maf Proteins , 2011, Molecular and Cellular Biology.

[19]  P. Carmeliet,et al.  Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling , 2011, Cancer cell.

[20]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[21]  M. Hersberger,et al.  Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis , 2011, European journal of immunology.

[22]  Renee E Haskew-Layton,et al.  Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. , 2011, Chemistry & biology.

[23]  Xiuwen Tang,et al.  Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. , 2011, Free radical biology & medicine.

[24]  Lucia Anna Muscarella,et al.  Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer , 2011, Epigenetics.

[25]  I. Bechmann,et al.  Sickle Hemoglobin Confers Tolerance to Plasmodium Infection , 2011, Cell.

[26]  K. Itoh,et al.  Nrf2 degron‐fused reporter system: a new tool for specific evaluation of Nrf2 inducers , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  T. Kensler,et al.  Nrf2: control of sensitivity to carcinogens , 2011, Archives of Toxicology.

[28]  W. Brück,et al.  Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.

[29]  Takafumi Suzuki,et al.  Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo. , 2011, Cancer research.

[30]  Masayuki Yamamoto,et al.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[32]  Donna D. Zhang,et al.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism , 2011, Proceedings of the National Academy of Sciences.

[33]  A. Lusis,et al.  NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. McMahon,et al.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals , 2010, Proceedings of the National Academy of Sciences.

[35]  M. Kwak,et al.  Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration , 2010, Science Signaling.

[36]  Masayuki Yamamoto,et al.  The Critical Role of Nitric Oxide Signaling, via Protein S-Guanylation and Nitrated Cyclic GMP, in the Antioxidant Adaptive Response* , 2010, The Journal of Biological Chemistry.

[37]  David J. Arenillas,et al.  Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis , 2010, Nucleic acids research.

[38]  G. Batist,et al.  Identification and Characterization of Novel Nrf2 Inducers Designed to Target the Intervening Region of Keap1 , 2010, Chemical biology & drug design.

[39]  Takafumi Suzuki,et al.  Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1 , 2010, Molecular and Cellular Biology.

[40]  M. Freeman,et al.  Cysteine-based regulation of the CUL3 adaptor protein Keap1. , 2010, Toxicology and applied pharmacology.

[41]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[42]  T. Ogura,et al.  Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains , 2010, Proceedings of the National Academy of Sciences.

[43]  T. Kensler,et al.  Nrf2: friend or foe for chemoprevention? , 2010, Carcinogenesis.

[44]  A. Mesecar,et al.  Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. , 2009, The Biochemical journal.

[45]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[46]  N. Kikuchi,et al.  Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer , 2009, Clinical Cancer Research.

[47]  S. Biswal,et al.  Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice , 2008, PloS one.

[48]  Masayuki Yamamoto,et al.  The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds , 2008, Molecular and Cellular Biology.

[49]  S. Reddy,et al.  Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling , 2008, Oncogene.

[50]  Paul Talalay,et al.  Direct and indirect antioxidant properties of inducers of cytoprotective proteins. , 2008, Molecular nutrition & food research.

[51]  Takafumi Suzuki,et al.  Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity , 2008, Molecular and Cellular Biology.

[52]  C. Wolf,et al.  Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha , 2007, Proceedings of the National Academy of Sciences.

[53]  S. Yokoyama,et al.  Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response , 2007, Molecular and Cellular Biology.

[54]  Akira Kobayashi,et al.  Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism , 2006, Biological chemistry.

[55]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[56]  Paul Talalay,et al.  Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[58]  J. D. Engel,et al.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation , 2003, Nature Genetics.

[59]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[60]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.